MedPath

A clinical study on the effect of Baladi Kashaya in the management of heavy menstrual bleeding.

Phase 3
Conditions
Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
Registration Number
CTRI/2023/10/058320
Lead Sponsor
Dr Neha Malik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients complaining of Asrigdara as a cardinal symptom.

1.Ritu Atipravitti ( excessive bleeding during menstruation),

2.Anritu pravrittti( intermenstrual bleeding) ,

3.Deergha Pravritti ( prolonged bleeding)

Exclusion Criteria

a.Use of IUCD

b.Patient with ongoing treatment of systemic disease like diabetes , hypertension.

c.Uterine & pelvic pathology like polyps,Friboid,Adenomyosis.

d.Endocrinal Diseases (Hypo/Hyper Thyroidism)

e.Non-Menstrual Causes for bleeding (Foreign body, Genital malignancy, Abortion, Postcoital)

f.Pregnancy

g.Hb% <7

h.PCOS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
control of bleedingTimepoint: 90 days
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath